Please use this identifier to cite or link to this item: https://etd.cput.ac.za/handle/20.500.11838/4082
DC FieldValueLanguage
dc.contributor.advisorMarnewick, Jeanine L.en_US
dc.contributor.advisorDocrat, Taskeenen_US
dc.contributor.authorChipofya, Eliasen_US
dc.date.accessioned2024-04-30T07:35:40Z-
dc.date.available2024-04-30T07:35:40Z-
dc.date.issued2024-
dc.identifier.urihttps://etd.cput.ac.za/handle/20.500.11838/4082-
dc.descriptionThesis (MSc (Biomedical Technology))--Cape Peninsula University of Technology, 2024en_US
dc.description.abstractOxidative stress, a key player in neurodegenerative disorders such as Alzheimer's and Parkinson's disease, is a critical target for therapeutic interventions. Plant polyphenols demonstrate substantial neuroprotective effects in numerous neurodegenerative disorders, underpinning future preclinical and clinical studies. South African Rooibos (Aspalathus linearis) herbal tea, which is widely consumed for its health benefits and caffeine-free nature, has been shown to positively affect various processes observed in the pathogenesis of neurodegenerative disorders. In this study, we investigate the neuroprotective potential of fermented and unfermented aqueous and ethanolic Rooibos extracts on neuroblastoma cells, addressing a critical gap in current research. Aqueous and ethanolic extracts [15-500 μg/mL] were evaluated in an SH-SY5Y cellular model subjected to oxidative stress induced by hydrogen peroxide (H2O2). The antioxidant properties of the extracts were measured using cell-free systems. The total antioxidant content and capacity of the Rooibos extracts were determined by measuring using total polyphenol content (TPC), trolox equivalent antioxidant capacity (TEAC) and ferric ion reducing antioxidant power (FRAP). HPLC was employed to quantify major phenolic compounds, revealing aspalathin as the predominant polyphenol. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to assess the maximum non-toxic dosage (MNTD) of Rooibos extracts against SH-SY5Y cells. Subsequently, the cells were pretreated with the MNTDs of Rooibos extracts, and thereafter exposed for 3 hours to 150 μM H2O2. The effect of Rooibos extracts on cell viability and metabolic activity was determined using MTT and intracellular adenosine triphosphate (ATP) assays; oxidative status was assessed using thiobarbituric acid reactive substance (TBARS), conjugated diene (CDs), protein carboxylation, and reduced glutathione (GSH) assays; and endogenous antioxidant enzyme activity in SH-SY5Y cells was assessed using superoxide dismutase (SOD) and catalase (CAT) colorimetric assays. In addition, the activities of lactate dehydrogenase (LDH) and caspase -3/7, -8, and -9 were used to measure cellular death. Rooibos extracts exhibited a dose-dependent increase in antioxidant capacity in cell-free systems. The results showed that treatment with Rooibos extracts did not reduce cell viability of SH-SY5Y cells. Furthermore, when SH-SY5Y cells were exposed to H2O2, Rooibos extracts exhibited dose-dependent cytoprotective effects. Rooibos fermented aqueous extract at 60 μg/mL increased (P≤0.05) intracellular ATP levels, while the fermented ethanolic extract at 125 and 250 μg/mL increased (P≤0.001) intracellular ATP levels and (P≤0.001), respectively. Both unfermented and fermented aqueous and ethanolic extracts reduced CDs, an early marker of lipid peroxidation (P≤0.01, and P≤0.001, when compared to cells treated only with H2O2), except for fermented aqueous extract at 60 μg/mL, where CDS formation was comparable to cells treated only with H2O2. Furthermore, a significant decrease in protein carbonyls was observed in cells pre-treated with 250 μg/mL of unfermented aqueous Rooibos extract (P≤0.01), 125 and 250 μg/mL of unfermented ethanolic Rooibos extract (P≤0.001) and (P≤0.05), respectively and 250 μg/mL of fermented ethanolic Rooibos extract (P≤0.001) compared to cells treated only with H2O2. Pre-treatment with 60 μg/mL of unfermented ethanolic Rooibos extract prevented H2O2 depletion of reduced GSH (P<0.05). Both Rooibos extracts significantly (P≤0.01, P≤0.001) restored endogenous antioxidant enzyme, CAT activity, with varying effects on SOD enzyme activity in the cells. The current study demonstrates that Rooibos, a renowned South African herbal tea at certain concentrations, may enhance the endogenous antioxidant defence system in oxidatively challenged H2O2 human neuroblastoma SH-SY5Y cells. However, this was not the case for all concentrations tested in this model, implying that Rooibos may possess pro-oxidant properties at certain concentrations. The interactions between Rooibos and H2O2 must be further elucidated. Nevertheless, these findings suggest a compelling avenue for the use of Rooibos in preventative strategies against neurodegenerative disorders, including Alzheimer's disease and Parkinson’s disease.en_US
dc.language.isoenen_US
dc.publisherCape Peninsula University of Technologyen_US
dc.subjectNeurodegenerative disordersen_US
dc.subjectOxidative stressen_US
dc.subjectAntioxidantsen_US
dc.subjectRooibosen_US
dc.subjectNeuroprotective agentsen_US
dc.subjectPhytochemicalsen_US
dc.subjectPlant extractsen_US
dc.subjectNervous system -- Degeneration -- Pathophysiologyen_US
dc.titleNeuroprotective effects of rooibos against H2O2-induced cytotoxicity in human neuroblastoma SH-SY5Y cellsen_US
dc.typeThesisen_US
dc.identifier.doihttps://doi.org/10.25381/cput.25429264.v2-
Appears in Collections:Biomedical Technology - Masters Degrees
Files in This Item:
File Description SizeFormat 
200611356_E_Chipofya_MSc.pdf2.5 MBAdobe PDFView/Open
Show simple item record

Page view(s)

754
Last Week
24
Last month
90
checked on Dec 17, 2024

Download(s)

135
checked on Dec 17, 2024

Google ScholarTM

Check

Altmetric


Items in Digital Knowledge are protected by copyright, with all rights reserved, unless otherwise indicated.